Trends and disparities in colorectal cancer among adults with diabetes mellitus in the United States: A retrospective analysis, 1999-2023.

M Mahmoud Tablawy (Faculty of Medicine Alazhar University, Cairo, Egypt) A Amro Ali (Community Regional Medical Center, Fresno, CA) A Alyaa Ahmed Ibrahim M Mohamed Fawzi Hemida F FNU Sahil (LUMHS Jamshoro, Jamshoro, Pakistan) A Abdelrhman H. Mohamed (Faculty of Medicine, Luxor University, Luxor, Egypt) A Abdelrahman Aly Mohamed (Faculty of Medicine, Helwan University, Cairo, Egypt) A Ahmed Sami Fdle (Egyptian Ministry of health, Cairo, Egypt) S Shehdev Meghwar (LUMHS Jamshoro, Jamshoro, Pakistan) F Fnu Urooba M Madina Memon (Liaquat University of Medical & Health Sciences, Jamshoro, Pakistan) A Ahmed Abdelaziz E Ehsanullah Alokozay (Faculty of Medicine, Kandahar University, Kandahar, Afghanistan) M Mina Nageh Hemaya (Tbilisi State University, Tbilisi, Georgia) M Mohamed Olama (Benha University Hospital, Banha, Egypt) F Fatma A. Rikabe (Radiation Oncology Department, Shefaa Al-Orman Oncology Hospital, Luxor, Egypt)

Abstract

e15674 Background: Colorectal cancer (CRC), the fourth leading cause of cancer-related deaths, affects approximately 1.5 million U.S. adults and is increasingly linked to diabetes. Diabetic patients face elevated mortality due to delayed detection, higher recurrence risk, reduced five-year survival, and poorer prognosis. This study assesses recent demographic trends in CRC mortality with diabetes as a contributing factor. Methods: We analyzed mortality data from the CDC WONDER Multiple Cause-of-Death dataset, using ICD-10 Codes: C18; C19; C20, and E10-E14. Age-adjusted mortality rates (AAMR) per 1,000,000 individuals and annual percentage changes (APC) were calculated by year, gender, race or ethnicity, and location. Results: Between 1999 and 2023, 79,568 deaths occurred from colorectal cancer in diabetic adults. The AAMR declined from 16.94 in 1999 to 13.01 in 2023 (AAPC: -1.15; 95%CI: -1.44 to -0.87). Males showed a higher AAMR of 17.17 versus 9.73 in females. Non-Hispanic (NH) Black or African American individuals had the highest AAMR (19.77), followed by Hispanic or Latino (14.23), NH White (12.48), and NH Asian or Pacific islander (9.29). AAMRs in non-metropolitan (18.52) areas were higher than in Metropolitan areas (13.49). The Midwest region exhibited the highest AAMR, followed by the South, West, and Northeast regions. State-level differences recorded Oklahoma having the highest AAMR (32.81) and Massachusetts the lowest (5.16). Conclusions: Mortality related to colorectal cancer in diabetic adults has declined significantly over the past two decades, disproportionately affecting non-Hispanic Black individuals, residents of non-metropolitan areas and the Midwest region. This emphasizes the need for targeted interventions and greater clinical sensitivity to demographic disparities. Deaths and age-adjusted mortality rates (AAMRs) per 1,000,000 for colorectal cancer related mortality among diabetic adults in the United States from 1999 to 2023. Variable Deaths (n) AAMR (95% CI) Overall 79,568 13.01 (12.58 to 13.44) SEX Male 43,494 17.17 (16.42 to 17.91) Female 36,074 9.73 (9.23 to 10.23) RACE/ETHNICITY NH Blacks 11,535 19.77(18.10 to 21.45) Hispanics 6,233 14.23(12.80 to 15.65) NH White 59,929 12.48(12.02 to 12.95) NH Asians 2,199 9.29 (7.72 to 10.87)

Article Details

Volume / Issue Vol. 44, Issue 16_suppl
Published June 01, 2026
ISSN 0732-183X
Publisher Lippincott Williams & Wilkins

Journal Info

Journal of Clinical Oncology

Lippincott Williams & Wilkins

ISSN: 0732-183X Health Sciences

Authors (16)

M

Mahmoud Tablawy

Faculty of Medicine Alazhar University, Cairo, Egypt

A

Amro Ali

Community Regional Medical Center, Fresno, CA

A

Alyaa Ahmed Ibrahim

M

Mohamed Fawzi Hemida

F

FNU Sahil

LUMHS Jamshoro, Jamshoro, Pakistan

A

Abdelrhman H. Mohamed

Faculty of Medicine, Luxor University, Luxor, Egypt

A

Abdelrahman Aly Mohamed

Faculty of Medicine, Helwan University, Cairo, Egypt

A

Ahmed Sami Fdle

Egyptian Ministry of health, Cairo, Egypt

S

Shehdev Meghwar

LUMHS Jamshoro, Jamshoro, Pakistan

F

Fnu Urooba

M

Madina Memon

Liaquat University of Medical & Health Sciences, Jamshoro, Pakistan

A

Ahmed Abdelaziz

E

Ehsanullah Alokozay

Faculty of Medicine, Kandahar University, Kandahar, Afghanistan

M

Mina Nageh Hemaya

Tbilisi State University, Tbilisi, Georgia

M

Mohamed Olama

Benha University Hospital, Banha, Egypt

F

Fatma A. Rikabe

Radiation Oncology Department, Shefaa Al-Orman Oncology Hospital, Luxor, Egypt